Clinical Trial

A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated March 21, 2025 (before its estimated July 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a 2-part, phase I/II, open-label, multicenter study designed to evaluate the safety, PK, PD and preliminary efficacy of TCC1727 tablets administered orally QD.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-07-23; most recent amendment 2025-03-18.
Status change: Not Yet Recruiting → Recruiting 2023-12-15
Trial Details
NCT Number NCT05970016
Lead Sponsor Beijing Tide Pharmaceutical Co., Ltd
Conditions Patients with Advanced Solid Tumors
Enrollment 56 participants
Start Date 2023-08-07
Primary Completion 2025-07-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-21